Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 1012-1017

  Kawai, Mariko ^a   Maruyama, Hiroki ^b   Bessho, Kazuhisa ^c   Yamamoto, Hiromitsu ^c   Miyazaki, Jun Ichi ^d   Yamamoto, Toshio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

BMP; Bone regeneration; Electroporation; Gene transfer; Vector

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; HOMODIMER; OSTEOGENIC PROTEIN 1; PLASMID CAGGS; PLASMID CAGGS BONE MORPHOGENETIC PROTEIN 2 BONE MORPHOGENETIC PROTEIN 7 CONJUGATE; PLASMID CAGGS BONE MORPHOGENETIC PROTEIN 2 CONJUGATE; PLASMID CAGGS BONE MORPHOGENETIC PROTEIN 7 CONJUGATE; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ELECTROPORATION; EXPRESSION VECTOR; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OSSIFICATION; OSTEOSYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TRANSIENT TRANSFECTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; BONE REGENERATION; CELL LINE; ELECTROPORATION; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MUSCLE, SKELETAL; OSTEOGENESIS; PROTEIN MULTIMERIZATION; RATS; TRANSFECTION;

RATTUS;

EID: 70449722764     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.099     Document Type: Article

References (26)

1. Kawakami S., Higuchi Y., and Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J. Pharm. Sci. 97 (2008) 726-745
2. Niidome T., and Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9 (2002) 1647-1652
3. Ferber D. Gene therapy: safer and virus-free?. Science 294 (2001) 1638-1642
4. Okubo Y., Bessho K., Fujimura K., Iizuka T., and Miyatake S. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem. Biophys. Res. Commun. 267 (2000) 382-387
5. Kaihara S., Bessho K., Okubo Y., Sonobe J., Kawai M., and Iizuka T. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats. Gene Ther. 11 (2004) 439-447
6. Nishikawa M., and Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene. Ther. 12 (2001) 861-870
7. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16 (1998) 867-870
8. Ogura T. In vivo electroporation: a new frontier for gene delivery and embryology. Differentiation 70 (2002) 163-171
9. Wells D.J. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther. 11 (2004) 363-369
10. Mir L.N. Application of electroporation gene therapy: past, current, and future. Methods Mol. Biol. 423 (2008) 3-17
11. Kawai M., Bessho K., Kaihara S., Sonobe J., Oda K., Iizuka T., and Maruyama H. Ectopic bone formation by bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous in vivo electroporation. Hum. Gene Ther. 14 (2003) 1547-1556
12. Cehng H., Jiang W., Phillips F.M., Haydon R.C., Peng Y., Zhou L., Luu H.H., An N., Breyer B., Vanicharn P., Szatkowski J.P., Park J.Y., and He T.C. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. Am. 85 (2003) 1544-1552
13. Li J.Z., Li H., Sasaki T., Holman D., Beres B., Dumont R.J., Pittman D.D., Hankins G.R., and Helm G.A. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther. 10 (2003) 1735-1743
14. Israel D.I., Nove J., Kerns K.M., Kaufman R.J., Rosen V., Cox K.A., and Wozney J.M. Heterodimeric bone morphogenetic proteins show enhanced activities in vitro and in vivo. Growth Factors 13 (1996) 291-300
15. Zhu W., Rawlins B.A., Boachie-Adjei O., Myers E.R., Arimizu J., Choi E., Lieberman J.R., Crystal R.G., and Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J. Bone Miner. Res. 19 (2004) 2021-2032
16. Zhao M., Zhao Z., Koh J.T., Jin T., and Franceschi R.T. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J. Cell Biochem. 95 (2005) 1-16
17. Zhu W., Kim L., Cheng C., Rawlins B.A., Boachie-Adjei O., Crystal R.G., and Hidaka C. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 39 (2006) 61-71
18. Kawai M., Bessho K., Maruyama H., Miyazaki J., and Yamamoto T. Simultaneous gene transfer of bone morphogenetic protein (BMP)-2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelt. disord. 7 (2006) 62
19. Wong E.T., Ngoi S.M., and Lee C.G.L. Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes. Gene Ther. 9 (2002) 337-344
20. Douin V., Bornes S., Creancier L., Rochaix P., Favre G., Prats A.C., and Couderc B. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors. BMC Biotechnol. 4 (2004) 16
21. Bouabe H., Faessler R., and Heesemann J. Improvement of reporter activity by IRES-mediated polycistronic reporter system. Nucleic Acids Res. 36 (2008) e28
22. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
23. Sheehan D., and Hrapchak B. Theory and Practice of Histotechnology. second ed. (1980), Battelle Press, Ohil
24. Zhang X., Xie C., Lin A.S., Ito H., Awad H., Lieberman J.R., Rubery P.T., Schwarz E.M., O'Keefe R.J., and Guldberg R.E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations + implications for functional tissue engineering. J. Bone Miner. Res. 20 (2005) 2124-2137
25. Park J., Gelse K., Frank S., von der Mark K., Aigner T., and Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/S periosteum- and fat-derived cells. J. Gene Med. 8 (2006) 112-125
26. De Bari C., Dell' Acco F., Vanlauwe J., Eyckmans J., Khan I.M., Archer C.W., Jones E.A., McGonagle D., Mitsiadis T.A., Pitzalis C., and Luyten F.P. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rhuem. 54 (2006) 1209-1221